MEIS1 rs12927866: Restless Legs Syndrome Genetics
The genetic variant rs12927866 is a single nucleotide polymorphism located within a non-coding region of the MEIS1 gene on chromosome 2. Genome-wide association studies have identified variants in this genomic region as risk factors for restless legs syndrome (RLS) and periodic limb movements in sleep. Carrying specific alleles at this locus confers a moderate statistical change in risk rather than serving as a direct diagnostic marker.
What each genotype means
Typical RLS risk
You carry two copies of the common C allele at rs12927866 in the MEIS1 gene region. In population-based studies, this baseline genotype is not associated with the increased risk of restless legs syndrome (RLS) or periodic limb movements in sleep linked to the alternative allele. However, RLS is a complex trait influenced by overall genetics, iron levels, and lifestyle factors, so having this genotype does not rule out developing symptoms.
Carried by approximately 45% to 50% of individuals of European ancestry, and generally more common in East Asian and African populations.
Moderately increased RLS risk
You carry one copy of the T risk allele at rs12927866 in the MEIS1 gene. Large genome-wide association studies show that each copy of this allele is statistically associated with a higher likelihood of developing restless legs syndrome (RLS) and periodic limb movements in sleep. This genetic marker represents a statistical susceptibility factor rather than a direct diagnosis or certainty of experiencing symptoms.
Carried by roughly 40% to 45% of individuals in European ancestry cohorts.
Elevated RLS risk
You carry two copies of the T risk allele at rs12927866 in the MEIS1 locus. Research indicates that homozygous carriers have the strongest statistical association with restless legs syndrome (RLS) and increased periodic limb movements during sleep among genotypes at this marker. While this genotype confers a higher relative genetic risk, it does not diagnose RLS or guarantee you will develop sleep-related movement symptoms.
Present in approximately 8% to 10% of individuals of European ancestry; observed at lower frequencies in most other global ancestries.
What is rs12927866?
The single nucleotide polymorphism rs12927866 is an intronic variant positioned within the MEIS1 gene on chromosome 2. Because it is located in an intron rather than a protein-coding exon, it does not alter the primary amino acid sequence of the resulting protein. Instead, non-coding single nucleotide changes in this locus often reside within or near cis-regulatory elements, such as highly conserved non-coding regions that function as transcriptional enhancers. Research cataloged in genomic databases indicates that variants in this region may influence the regulatory architecture and transcriptional efficiency of nearby target genes.
The Biological Role of the MEIS1 Gene
The MEIS1 gene encodes a homeobox-containing transcription factor essential for normal embryonic and neural development. It plays a pivotal role in establishing motor neuron pool identity, guiding neuromuscular connectivity, and patterning the central nervous system. Expression analyses have revealed that MEIS1 is present in the dopaminergic neurons of the substantia nigra, the red nucleus, and specific cerebellar motor circuits. In addition, functional molecular studies have linked MEIS1 activity to systemic and central nervous system iron homeostasis, a biological pathway widely implicated in the pathophysiology of sensorimotor sleep disorders.
Scientific Research and Restless Legs Syndrome
Multiple genome-wide association studies have mapped genetic susceptibility for restless legs syndrome (RLS) and periodic limb movements during sleep (PLMS) to the MEIS1 locus. Functional studies suggest that risk-associated haplotypes in this chromosomal region correlate with altered or reduced expression of MEIS1 transcript and protein levels in human neural tissues. However, across the general population, common polygenic variants in MEIS1 account for only a fraction of total disease heritability. Current clinical consensus classifies the statistical evidence for rs12927866 as limited to trait association, meaning it acts as an incremental susceptibility factor rather than an independent causative mutation.
Population Patterns and Frequency
Allele distributions for MEIS1 variants, including rs12927866, vary significantly across global cohorts. In European ancestry populations, the minor allele frequency is approximately 0.30, indicating that both heterozygous and homozygous genotypes are commonly observed in healthy populations. Data harmonized across reference repositories such as gnomAD demonstrate differing baseline frequencies in other continental populations, including African, Asian, and Admixed American cohorts. Because these allele shifts occur naturally in human genetic diversity, population-specific context is critical when interpreting association studies.
Clinical Implications and Interpretation
Understanding your rs12927866 genotype provides educational insights into personal genetic variation, but it cannot be used to diagnose or predict restless legs syndrome. Complex sensorimotor conditions depend heavily on environmental influences, including serum ferritin and iron status, kidney health, lifestyle, and co-occurring medical conditions. Direct-to-consumer genetic findings should not prompt changes in medication or supplementation. Individuals experiencing persistent discomfort in their limbs, irresistible urges to move during rest, or disrupted sleep should consult a qualified physician or sleep specialist for a comprehensive clinical assessment.
How common is this variant?
The minor allele frequency for rs12927866 is approximately 0.30 across European ancestry populations, while frequencies vary across African, Asian, and Hispanic populations in global reference cohorts.
Frequently asked questions
Does having the risk genotype mean I will develop restless legs syndrome?
No, carrying a risk allele does not mean you will develop restless legs syndrome. RLS is a complex, multifactorial disorder shaped by iron levels, age, lifestyle, and many other genetic factors, and many carriers of risk alleles remain entirely symptom-free.
Can rs12927866 genetic testing be used as a medical diagnosis?
Genetic tests for rs12927866 are not diagnostic tools. Restless legs syndrome is diagnosed clinically by a physician based on specific medical criteria, medical history, and sleep evaluations.
How does MEIS1 influence movement and sleep in the brain?
MEIS1 encodes a developmental transcription factor involved in forming motor coordination circuits and regulating iron processing within the nervous system. Dysregulation in these motor and dopaminergic circuits is believed to contribute to involuntary leg movements and sensory restlessness.
What actions should I take if I have sleep disruption and this variant?
If you experience restless sensations, an urge to move your legs at rest, or daytime fatigue, you should consult a healthcare provider. A physician can check your iron and ferritin levels, evaluate secondary causes, and recommend evidence-based care.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12927866?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29